Srinivasan Vijay, Spinella Philip C, Drott Henry R, Roth Carey L, Helfaer Mark A, Nadkarni Vinay
Pediatric Critical Care Medicine, The Children's Hospital of Philadelphia, Division of Critical Care Medicine, Philadelphia, PA, USA.
Pediatr Crit Care Med. 2004 Jul;5(4):329-36. doi: 10.1097/01.pcc.0000128607.68261.7c.
To study the association of timing, duration, and intensity of hyperglycemia with pediatric intensive care unit (PICU) mortality in critically ill children.
Retrospective cohort study.
PICU of a university-affiliated, tertiary care, children's hospital.
A total of 152 critically ill children receiving vasoactive infusions or mechanical ventilation.
None.
With institutional review board approval, we reviewed a cohort of 179 consecutive children, 1 mo to 21 yrs of age, treated with mechanical ventilation or vasoactive infusions. We excluded 18 with <3 microg.kg(-1).min(-1) dopamine only, diabetes, or solid organ transplant and nine who died within 24 hrs of PICU admission. Peak blood glucose (BG) and time to peak BG during PICU admission, duration of hyperglycemia (percentage of PICU days with any BG of >126 mg/dL), and intensity of hyperglycemia (median BG during first 48 PICU hours) were analyzed for association with PICU mortality using chi-square, Student's t-test, and logistic regression.
Peak BG of >126 mg/dL occurred in 86% of patients. Compared with survivors, nonsurvivors had higher peak BG (311 +/- 115 vs. 205 +/- 80 mg/dL, p <.001). Median time to peak BG was similar in nonsurvivors (23.5 hrs; interquartile ratio, 5-236 hrs) and survivors (19 hrs; interquartile ratio, 6-113 hrs). Duration of hyperglycemia was longer in nonsurvivors (71% +/- 14% of PICU days) vs. survivors (37% +/- 5% of PICU days, p <.001). Nonsurvivors had more intense hyperglycemia during the first 48 hrs in the PICU (126 +/- 38 mg/dL) vs. survivors (116 +/- 34 mg/dL, p <.05). Univariate logistic regression analysis showed that peak BG and the duration and intensity of hyperglycemia were each associated with PICU mortality (p <.05). Multivariate modeling controlling for age and Pediatric Risk of Mortality scores showed independent association of peak BG and duration of hyperglycemia with PICU mortality (p <.05).
Hyperglycemia is common in critically ill children. Peak BG and duration of hyperglycemia are independently associated with mortality in our PICU. A prospective, randomized trial of strict glycemic control in this subset of critically ill children who are at high risk of mortality is both warranted and feasible.
研究危重症患儿高血糖的发生时间、持续时间及强度与儿科重症监护病房(PICU)死亡率之间的关系。
回顾性队列研究。
一所大学附属的三级医疗儿童医院的PICU。
共有152名接受血管活性药物输注或机械通气的危重症患儿。
无。
经机构审查委员会批准,我们回顾了一组连续的179名年龄在1个月至21岁之间、接受机械通气或血管活性药物输注治疗的患儿。我们排除了仅使用<3μg·kg⁻¹·min⁻¹多巴胺、患有糖尿病或实体器官移植的18名患儿,以及在PICU入院后24小时内死亡的9名患儿。分析PICU住院期间的血糖峰值(BG)、达到血糖峰值的时间、高血糖持续时间(PICU住院日中任何BG>126mg/dL的天数百分比)和高血糖强度(PICU最初48小时内的BG中位数)与PICU死亡率的相关性,采用卡方检验、学生t检验和逻辑回归分析。
86%的患者血糖峰值>126mg/dL。与幸存者相比,非幸存者的血糖峰值更高(311±115 vs. 205±80mg/dL,p<.001)。非幸存者达到血糖峰值的中位时间(23.5小时;四分位间距,5 - 236小时)与幸存者(19小时;四分位间距,6 - 113小时)相似。非幸存者的高血糖持续时间更长(占PICU住院日的71%±14%),而幸存者为(占PICU住院日的37%±5%,p<.001)。非幸存者在PICU最初48小时内的高血糖强度更高(126±38mg/dL),而幸存者为(116±34mg/dL,p<.05)。单因素逻辑回归分析显示,血糖峰值、高血糖持续时间和强度均与PICU死亡率相关(p<.05)。多因素模型在控制年龄和儿科死亡风险评分后显示,血糖峰值和高血糖持续时间与PICU死亡率独立相关(p<.05)。
高血糖在危重症患儿中很常见。血糖峰值和高血糖持续时间与我们PICU的死亡率独立相关。对这一高死亡风险的危重症患儿亚组进行严格血糖控制的前瞻性随机试验既有必要也可行。